z-logo
open-access-imgOpen Access
Activated Protein C Protects Against Myocardial Ischemia/ Reperfusion Injury via Inhibition of Apoptosis and Inflammation
Author(s) -
Sarah T.B.G. Loubele,
C. Arnold Spek,
Peter Leenders,
René van Oerle,
Hella L. Aberson,
Karly Hamulyák,
Gary Ferrell,
Charles T. Esmon,
Henri M.H. Spronk,
Hugo Ten Cate
Publication year - 2009
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.109.188656
Subject(s) - inflammation , medicine , reperfusion injury , protein c , apoptosis , ischemia , pharmacology , myocardial infarction , mediator , immunology , biology , biochemistry
In spite of major advances in reperfusion therapy for patients presenting with acute coronary syndrome, long-term morbidity is still substantial. A limitation of initial treatment of myocardial ischemia is the lack of prevention of ischemia/reperfusion (I/R) injury. Activated protein C (APC), a crucial mediator in the coagulation process, plays a prominent role in the crosstalk between coagulation and inflammation and provides cytoprotective effects via inhibition of apoptosis and inflammation in several human and animal studies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom